The open index of psychedelic research

An Artificial Intelligence Driven Approach to Optimize Patient Selection for a Transitional Pain Service

Mechanisms of anti-depressant and anti- alcohol effects of ketamine in patients with alcohol use disorder

Mollaahmetoglu M, Krecke J, Oldfield C +7

Psychedelics Shift Decision Strategies and Reconfigure Orbitofrontal Dynamics

Delgado-Sallent, Cristina, Sanaa, Ahmed, Benjamin, Lee +5

Ayahuasca treatment reduces 50-kHz ultrasonic vocalizations and modifies mesocorticolimbic monoamine neurochemistry in rats.

De Souza CP, de Rosso VT, Daneluz DM +9

Worsening of Depression and Anxiety With Psilocybin: A Case Report in Cyclothymia.

Ghaemi SN

Alleviating Suicidality by Combining Psychotherapy and IM Ketamine for Rapid Treatment in the Emergency Department

Estimated Health and Economic Outcomes of Medically Monitored Ibogaine for Opioid Use Disorder in the United States

Wagner, T, Lardieri, Gaetano

PSYCHIATRY The Case for Starting Over

Peled A

U.S. Veterans and Psychedelics: Prevalence of Use and Policy Preferences.

Priest M, Schell TL, Senator B +1

Reduced egocentricity after psilocybin in patients with alcohol use disorder: a pilot randomized controlled trial

Bukowski H, de Timary P, Belahda D +4

Mixed toxin profiles in two new and one known species of <i>Inocybe (Inocybaceae)</i> from northern China.

Liang JQ, Chen X, Liu TZ +7

REAL-KET: Real-world Evaluation of Antidepressant response to Low-dose Ketamine in an Observational Study.

Comment on "Urological symptoms following ketamine treatment for psychiatric disorders: A systematic review".

Taj Wali Khan N, Khan H, Ahmed B +1

Characterization of Ketamine-Induced Neurotoxicity in PND7 Rats as a Model of Pediatric Anesthesia.

Canesi S, Bianchi D, Longo M +7

Evaluation of the Efficacy and Safety of Multimodal Sedation with Dexmedetomidine and Ketamine (Ketodex) at Different Ratios: A Randomized Clinical Trial

Torres LAM, Heimer MV, Maciel TF +4

When psychedelic discourse meets local narrative: Selective uptake of psychedelic meanings surrounding mad honey in Nepal.

Sznitman SR, Tiwari S

Psychedelic protects against chemotherapy-induced nerve damage.

Kingwell K

Moving beyond 5-HT<sub>2A</sub>: language models map neurotransmitter receptors to experiential semantics.

Suresh P, Kins J, Levkovskyy L +6

EEG Correlates of Subjective Experience During and Following Psychedelic in Humans: A Scoping Review

Multimodal predictors of response to intravenous ketamine in treatment-resistant depression: toward personalized treatment in major depressive and bipolar disorders.

Malewska-Kasprzak M, Rybakowski F, Dmitrzak-Weglarz M

Targeting the serotonin 1B receptor for the treatment of depression and anxiety.

Fleury S, Nautiyal KM

No Heavy Drinking Days and Percentage of Days Abstinent in a Randomized Trial of Adjunctive Ketamine for Alcohol Use Disorder: Secondary Analysis of the KARE Trial

Morgan CJ, Nutt DJ

Spiral brain dynamics track the temporal unfolding of subjective intensity during the <i>N,N</i> -dimethyltryptamine experience

Sawicka G, Martínez-Marín M, Timmermann C +5

Ketamine Alters Tuning of Neural and Behavioral Spatial Working Memory Precision.

Rahmati M, Moujaes F, Suljic NP +22